Trv Gp Vi LLC Purchases New Shares in Septerna, Inc. $SEPN

Trv Gp Vi LLC acquired a new stake in shares of Septerna, Inc. (NASDAQ:SEPN) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,211,659 shares of the company’s stock, valued at approximately $141,048,460,000. Septerna comprises 60.7% of Trv Gp Vi LLC’s investment portfolio, making the stock its biggest holding. Trv Gp Vi LLC owned 0.09% of Septerna as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Goldman Sachs Group Inc. increased its holdings in shares of Septerna by 86.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,715,129 shares of the company’s stock worth $75,698,000 after buying an additional 1,260,409 shares during the last quarter. BlackRock Inc. bought a new position in shares of Septerna in the 2nd quarter valued at about $64,706,000. Vanguard Group Inc. lifted its holdings in shares of Septerna by 7.4% in the 3rd quarter. Vanguard Group Inc. now owns 1,518,757 shares of the company’s stock valued at $28,568,000 after acquiring an additional 104,394 shares during the last quarter. ADAR1 Capital Management LLC grew its position in Septerna by 38.9% in the third quarter. ADAR1 Capital Management LLC now owns 1,176,491 shares of the company’s stock worth $22,130,000 after acquiring an additional 329,264 shares in the last quarter. Finally, Janus Henderson Group PLC purchased a new position in Septerna in the first quarter worth about $21,334,000.

Analyst Upgrades and Downgrades

SEPN has been the topic of a number of recent research reports. Raymond James Financial restated a “strong-buy” rating and set a $49.00 price objective on shares of Septerna in a research report on Tuesday, August 11th. Guggenheim lifted their target price on Septerna from $45.00 to $51.00 and gave the stock a “buy” rating in a report on Tuesday, August 11th. Stifel Nicolaus set a $49.00 target price on Septerna in a research report on Tuesday, August 11th. Weiss Ratings restated a “sell (d-)” rating on shares of Septerna in a report on Friday, July 17th. Finally, JonesTrading lifted their price objective on shares of Septerna from $43.00 to $62.00 and gave the stock a “buy” rating in a research note on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Septerna currently has an average rating of “Moderate Buy” and a consensus target price of $51.33.

Insider Transactions at Septerna

In other news, SVP Daniel D. Long sold 3,334 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $34.47, for a total value of $114,922.98. Following the sale, the senior vice president directly owned 96,412 shares in the company, valued at approximately $3,323,321.64. This represents a 3.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Samira Shaikhly sold 2,178 shares of the firm’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $35.18, for a total value of $76,622.04. Following the sale, the insider directly owned 793 shares of the company’s stock, valued at $27,897.74. This represents a 73.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 72,828 shares of company stock worth $2,684,314. 5.80% of the stock is currently owned by company insiders.

Septerna Trading Down 0.9%

Shares of NASDAQ:SEPN opened at $43.80 on Wednesday. Septerna, Inc. has a 12 month low of $10.74 and a 12 month high of $51.10. The company has a market capitalization of $2.04 billion, a price-to-earnings ratio of -81.11 and a beta of 2.29. The firm’s 50-day moving average is $36.37 and its 200 day moving average is $29.94.

Septerna (NASDAQ:SEPN) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.14. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.57%. The business had revenue of $26.75 million during the quarter, compared to the consensus estimate of $19.22 million. As a group, equities analysts forecast that Septerna, Inc. will post -1.36 EPS for the current fiscal year.

About Septerna

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.